Risk factor
Negligible price volatility
Profitability factor
Somewhat favourable analyst view
In Guru Portfolios
Portfolio Weight (%)
Change
Fund
Portfolio Weight (%)
Change
Fund
Portfolio Weight (%)
Change
Fund
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
About
Thermo Fisher Scientific Inc. is a prominent global entity that delivers a comprehensive suite of scientific instrumentation, specialized diagnostic offerings, laboratory supplies, biopharmaceutical services, and life science solutions. Its operational footprint extends across North America, Europe, Asia-Pacific, and other international regions. The company's Life Sciences Solutions division furnishes essential reagents, sophisticated instruments, and various consumables vital for biological and medical research, the advancement and manufacture of drugs and vaccines, and the identification of infections and diseases. This segment, encompassing biosciences, genetic sciences, and bioproduction, serves a broad spectrum of clients including pharmaceutical and biotechnology firms, agricultural businesses, clinical facilities, healthcare providers, academic institutions, and government agencies. Through its Analytical Instruments segment, the company supplies cutting-edge instruments, complementary consumables, software, and services to diverse sectors. These include pharmaceutical and biotechnology companies, academic and government research centers, environmental organizations, various industrial clients, and clinical diagnostic laboratories. The Specialty Diagnostics unit offers an array of diagnostic tools, including liquid, pre-mixed, and freeze-dried immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and specialized equipment. This segment also develops, produces, and markets complete blood test systems for the clinical detection and ongoing management of allergies, asthma, and autoimmune disorders. Additionally, it provides dehydrated and prepared culture media, sample collection and transport systems, related instrumentation, consumables, and human leukocyte antigen (HLA) typing and testing crucial for organ transplantation, as well as other general healthcare items. The Laboratory Products and Biopharma Services segment provides an extensive range of laboratory supplies, manages distribution for research and safety products, and delivers pharmaceutical services, including support for clinical research. The company's vast portfolio of products and services is distributed through multiple avenues: a dedicated direct sales team, customer service professionals, e-commerce platforms, and a network of third-party distributors. These offerings are marketed under well-recognized brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Founded in 1956, Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD
Target Price
The average target price of TMO is 616 and suggests 29.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa